Michael Walter

The Shockwave C2 Aero Fly Coronary IVL Catheter from Johnson & Johnson MedTech is now available. In addition, the company announced, the next-generation device will be featured in its booth at TCT 2026.

“Instead of asking only whether a patient will survive, we need to ask whether they will be able to maintain the life they value after discharge,” one researcher explained.

Overall, more than 950,000 clinicians submitted queries to a popular AI platform from January 2024 to June 2026. Cardiovascular care was a common topic, especially questions about specific treatments and medications.

One of the world's most well-known publications just dropped a new list of 300 different inventions. Cardiologists and other cardiology professionals may recognize a few entries.

Cardiologists appear to be thriving in the face of adversity. Even as the specialty juggles an aging population, a workforce shortage and unfavorable reimbursement policies, compensation and productivity continue to climb.

The recent PRO-TAVI trial showed that care teams can safely perform PCI at a later date when patients undergoing TAVR present with concomitant coronary artery disease. According to this latest analysis, however, there may still be certain patients who benefit from undergoing PCI prior to TAVR.

William Holding, a veteran healthcare consultant, spoke to Cardiovascular Business about the ever-changing cardiology industry. Should private practices sell or stay independent? How has private equity impacted the market? He answered those questions and many more.

Atherectomy is still the go-to treatment option for many clinicians, but peripheral IVL appears to be gaining momentum as time goes on.

Researchers tracked years of data, noting that strokes and other neurological adverse events reduce a patient's odds of survival.

The product at the heart of this recall is a dietary supplement taken to boost energy and performance when exercising. The FDA previously warned the public not to take it due to the potential side effects.